Nelarabine from Japan
Nelarabine is a prodrug of ara-G with guanosine structure used for T-cell acute lymphoblastic leukemia. As an aromatic heterocyclic pharmaceutical, it falls under HTS 2934.99.30.00 drug classification.
Duty Rate — Japan → United States
15%
Rate breakdown
9903.04.628.5%Pharmaceuticals: patented pharma from JP/EU/KR/CH/LI — 15% floor rate
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Provide prodrug conversion rate data and plasma stability profiles
• Certify absence of desamino impurities critical for efficacy
• Include neurotoxicity risk management documentation in safety data sheet